ABIOMED INC Quarterly Depreciation in USD from Q2 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Abiomed Inc quarterly/annual Depreciation history and growth rate from Q2 2015 to Q3 2022.
  • Abiomed Inc Depreciation for the quarter ending September 30, 2022 was $6.3M, a 4.55% decline year-over-year.
  • Abiomed Inc annual Depreciation for 2021 was $25.9M, a 12.1% increase from 2020.
  • Abiomed Inc annual Depreciation for 2020 was $23.1M, a 14.9% increase from 2019.
  • Abiomed Inc annual Depreciation for 2019 was $20.1M, a 44.6% increase from 2018.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $6.3M -$300K -4.55% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $6.1M -$300K -4.69% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q3 2021 $6.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $6.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q2 2018 $2.96M +$496K +20.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-02
Q2 2017 $2.46M +$1.06M +75.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q2 2016 $1.41M +$743K +112% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q2 2015 $663K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.